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Abstract
Background: In the brain, the inducible form of heme oxygenase (HO-1) has been recently demonstrated to
exacerbate early brain injury produced by intracerebral hemorrhagic stroke which incident rate has been correlated
with cigarette smoking previously. Interestingly, cigarette smoke (CS) or chemicals present in CS have been shown
to induce HO-1 expression in various cell types, including cerebral endothelial cells. However, the mechanisms
underlying CS modulating HO-1 protein expression are not completely understood in the brain vessels.
Objective: The aim of the present study was to investigate the mechanisms underlying CS modulating HO-1
protein expression in cerebral endothelial cells.
Methods: Cultured cerebral endothelial cells (bEnd.3) were used to investigate whether a particulate phase of
cigarette smoke extract (PPCSE) regulates HO-1 expression and to investigate the molecular mechanisms involved
in HO-1 expression in bEnd.3 cells.
Results: We demonstrated that PPCSE (30 μg/ml) significantly induced HO-1 protein expression and its enzymatic
activity in bEnd.3 cells determined by western blotting and bilirubin formation, respectively. PPCSE-induced HO-1
expression was mediated through phosphatidylcholine phospholipase C (PC-PLC), PKCδ, and PI3K/Akt which were
observed by pretreatment with their respective pharmacological inhibitors or transfection with dominant negative
mutants of PKCδ and Akt. ROS scavenger (N-acetyl-L-cysteine, NAC) blocked the PPCSE-induced ROS generation
and HO-1 expression. Pretreatment with selective inhibitors of PKCδ (rottlerin) and NADPH oxidase
[diphenyleneiodonium chloride (DPI) and apocynin (APO)] attenuated the PPCSE-induced NADPH oxidase activity,
ROS generation, and HO-1 expression. In addition, we found that PPCSE induced PI3K/Akt activation via NADPH
oxidase/ROS-dependent PDGFR phosphorylation.
Conclusions: Taken together, these results suggested that PPCSE-induced HO-1 expression is mediated by a PC-
PLC/PKCδ/NADPH oxidase-dependent PDGFR/PI3K/Akt pathway in bEnd.3 cells.
Background
Cigarette smoke (CS) is a complex aerosol that can be
separated into gas and particulate phases. Particulate
phase of CS extract (PPCSE), such as lipophilic compo-
nents, could pass the lipid bilayer of respiratory mem-
branes [1] into blood stream. Therefore, the damage of
CS not only limits to lung tissue but also vascular system.
CS is a known risk factor not only for peripheral
cardiovascular inflammation-related diseases [2,3] but
also for cerebrovascular diseases, such as stroke [4].
In the brain, the inducible form of heme oxygenase
(HO) plays as a rate-limiting enzyme in the process of
oxidative degradation of pro-oxidant heme into potent
antioxidants [5]. HO-1 has been recently demonstrated
to exacerbate early brain injury produced by intracerebral
hemorrhagic stroke [6]. Interestingly, CS or chemicals
present in CS have been shown to induce HO-1 expres-
sion in various cell types [7-10] including cerebral
endothelial cells [11]. Therefore, PPCSE-induced HO-1
expression in cerebral vessels might be an important
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dent rate has been correlated with cigarette smoking
previously [4].
High levels of reactive components and radicals present
in CS [12,13] trigger cytotoxic effects with increasing
dosages in various cell types [14,15]. Different facets of
CS-induced cytotoxic stress have been extensively stu-
died in peripheral endothelial cells. Previous studies have
reported that CS-induced HO-1 expression was mediated
through activation of PKC [16], p42/p44 MAPK [17],
JNK1/2 [10], PI3K/Akt [18], transcription factor Nrf2 [7],
CdRE [19], and Bach1 [8] in various cell types. Recently,
we also found the involvement of NADPH oxidase/ROS/
PDGFR pathway in PPCSE-induced HO-1 expression in
mouse cultured brain endothelial cells (bEnd.3) [11].
However, the molecular mechanisms underlying PPCSE-
induced HO-1 expression were not completely under-
stood in cerebral vessels.
In the present study, we used PPCSE to investigate the
molecular and cellular mechanisms of PPCSE-induced
HO-1 expression in bEnd.3. Our results demonstrated
that PPCSE-induced HO-1 expression was mediated
through a PKCδ/NADPH oxidase/ROS/PDGFR/PI3K/
Akt cascade.
Methods
Materials
Anti-HO-1 antibody was purchased from Santa Cruz
(Santa Cruz, CA). Anti-phospho-PDGFR and anti-phos-
pho-Akt antibodies were purchased from Cell Signaling
(Danver, MA). Anti-PKC-δ and anti-Akt antibodies were
purchased from Santa Cruz (Santa Cruz, CA). AG1296,
diphenyleneiodonium chloride (DPI), LY294002, wort-
mannin (Wort), GF109203X, rottlerin (Rott), Gö6976,
U73122 and D609 were purchased from Biomol (Ply-
mouth Meeting, PA). Apocynin (APO) was purchased
from ChromaDex (Santa Ana, CA). CM-H2DCFDA was
from Molecular Probes (Eugene, OR). N-acetyl-L-cysteine
(NAC) and other chemicals were purchased from Sigma
(St. Louis, MO).
Preparation of PPCSE
PPCSE was prepared with modification of previously
described method [20,21]. In brief, 10 cigarettes (Long
Life™, Taiwan Tobacco and Liquor Production, Taipei,
Taiwan; 0.9 mg nicotine/cigarette) were combusted and
the smoke was sucked through a standard glass-fiber
enabled Cambridge filter with a constant flow of 0.3 liters/
min with an air compressor and this filter has been
reported to trap > 99% of the smoke particulate matter
[20]. The smoke filter was quickly dried with a hot plate
and the raised weight in each filter was defined as the
amount of PPCSE. On average, each cigarette smoke gen-
erated ~39.5 mg of PPCSE using this method. The PPCSE
was dissolved by soaking the filter in DMSO for 30 min at
room temperature. The solution containing PPCSE was
centrifuged and the supernatant was collected and filtered
using a 0.22-μm filter column (Millipore, Bedford, MA).
The PPCSE stock solution (20 mg/ml of PPCSE containing
0.36 mg/ml of nicotine) was divided into microtubes (each
15 μl) and stored immediately at -80°C. Before each
experiment, the frozen PPCSE stock solution was
defrosted and further diluted to the desired concentration
with cell medium. The quality of the PPCSE solution was
assessed based on the absorbance at 302 nm, which is the
specific absorption spectrum of peroxynitrite. Therefore,
the concentration of DMSO in the testing solution was
always < 1% to prevent possible cytotoxicity or other
effects.
Cell culture
Mouse brain endothelial cells (bEnd.3) were purchased
from Bioresource Collection and Research Centre (BCRC
60515; Hsinchu, Taiwan) and grew in DMEM/F-12 con-
taining 10% FBS and antibiotics (100 U/ml penicillin G,
100 μg/ml streptomycin and 250 ng/ml fungizone) at 37°
C in a humidified 5% CO2 atmosphere. When the cul-
tures grown to confluence (about 4 days), cells were
released with 0.05% (w/v) trypsin/0.53 mM EDTA for 5
min at 37°C. The cell suspension was diluted with
DMEM/F-12 containing 10% FBS to a concentration of 2
×1 0
5 cells/ml. The cell suspension was plated onto 6-
well culture plates (2 ml/well) and 10-cm culture dishes
(10 ml/dish) for the measurement of protein and RNA
expression, respectively. Culture medium was changed in
every 24 h of the 3 consecutive days. Experiments were
performed with cells from passages 5 to 13.
Enzymatic assay for HO-1 activity
HO activity was measured based on the levels of bilirubin
formation using a microsomal fraction of cells as a source
[22]. Briefly, bEnd.3 cells were homogenized and sonicated
before centrifuging at 15000 × g for 40 min at 4°C. The
supernatant (500 μg of protein) was mixed with NADH-
containing buffer (1 mM NADH, 2 mM glucose 6-phos-
phate, 2 U glucose-1-phosphate dehydrogenase, 600 μgo f
biliverdin reductase, 1 mM potassium phosphate buffer,
and 25 μMh e m i n )f o r6 0m i na t3 7 ° Ci nt h ed a r k .T h e
reaction without NADH was served as a blank. The reac-
tions were stopped by placing the mixture on ice and sub-
sequently scanned with a spectrophotometer. The amount
of bilirubin was determined by the difference in optical
density units between 470 and 550 nm.
Determination of ROS production
The intracellular H2O2 levels were determined by mea-
suring fluorescence of DCFH-DA. For the purpose of
these experiments, cells were washed with warm HBSS
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37°C for 45 min. Subsequently, HBSS containing DCFH-
DA was removed and replaced with a fresh medium.
Cells were then treated with PPCSE with/without pre-
treatment of a ROS scavenger or inhibitors of NADPH
oxidase. Cells were washed twice with PBS and detached
with trypsin/EDTA, and the fluorescence intensity of the
cells was analyzed using a FACScan flow cytometer (BD
Biosciences, San Jose, CA) at 495 nm excitation and 529
nm emission for DCF.
Determination of NADPH oxidase activity by
chemiluminescence assay
The NADPH oxidase activity in intact cells was
assayed by lucigenin chemiluminescence assay, as pre-
viously described [23] with modifications. After incu-
bation, cells were gently scraped and centrifuged at
400 × g for 10 min at 4°C. The cell pellet was resus-
pended with 35 μl/per well of ice-cold RPMI 1640
medium, and the cell suspension was kept on ice. To a
final 200 μl volume of pre-warmed (37°C) RPMI 1640
medium containing NADPH (1 μM) or lucigenin (20
μM), 5 μlo fc e l ls u s p e n s i o n( 0 . 2×1 0
5 cells) was
added to initiate the reaction followed by immediate
measurement of chemiluminescence in an Appliskan
luminometer (Thermo
®)i na no u t - o f - c o i n c i d e n c e
mode. Appropriate blanks and controls were estab-
lished, and chemiluminescence was recorded. Neither
NADPH nor NADH enhanced the background chemi-
luminescence of lucigenin alone (30-40 counts per
min). Chemiluminescence was continuously measured
for 12 min, and the activity of NADPH oxidase was
expressed as counts per million cells.
PC-PLC activity assay
PC-PLC activity assay was determined as described pre-
viously [24]. In brief, we prepared the enzyme and used L-
a-phosphatidylcholine (Sigma) as the substrate of phos-
phatidylcholine-specific phospholipase C (PC-PLC). The
optical density was measured at wavelength of 660 nm.
The enzyme activity was expressed as nmol per min per
mg of protein (nmol/min/mg protein).
PKC Kinase Activity Assay
Protein kinase C activity was performed according to
instructions of manufacturer (Enzo Life Science, #ADI-
EKS-420A), which is based on a solid phase enzyme
linked immuno-absorbent assay (ELISA) that utilizes a
specific synthetic peptide as a substrate for subtypes of
PKCs, including δ, a, b, h,a n dζ,a n dap o l y c l o n a la n t i -
body that recognizes the phosphorylated form of the
substrate. The optical density was measured at wave-
length of 450 nm. The enzyme activity was expressed as
a relative activity.
Western blot analysis
After incubation, cells were washed with ice-cold PBS,
homogenization buffer A (20 mM Tris-HCl, pH 8.0,
10 mM EGTA, 2 mM EDTA, 2 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 25 μg/ml aprotinin, 10 μg/
ml leupeptin) was added and the cells were scraped into a
1.5-ml tube with a rubber policeman. The suspension was
sonicated for 10 s at output 4 with a sonicator (Misonix,
Farmingdale, NY) and centrifuged at 8000 rpm for 15 min
at 4°C. The supernatant was collected as the cytosol with
cellular membrane fractions and the pellet as the nuclear
fraction. The supernatant was then centrifuged at 14,000
rpm for 60 min at 4°C to separate cytosol fraction and cel-
lular membrane fraction. The pellet was resuspended in
300 μl of homogenization buffer B (1% Triton X-100 in
buffer A) and sonicated for 10 s. The suspension was cen-
trifuged at 14,000 rpm for 10 min at 4°C. The supernatant
was collected as a nuclear lysate fraction. On the other
hand, after the incubation, cells were washed, scraped, col-
lected, and centrifuged at 45000 × g at 4°C for 1 h to yield
the whole cell extract. The denatured samples were sub-
jected to 10% SDS-PAGE and the protein fractions were
transferred to nitrocellulose membrane. Membranes
were incubated with desired primary antibodies for 24 h at
4°C, and then incubated with horseradish peroxidase-
conjugated anti-goat antibody for 1 h at room tempera-
ture. The immunoreactive bands were developed with
ECL reagents. GAPDH served as internal controls for all
the experiments.
Transient transfection with dominant negative plasmids
Cells were cultured in 12-well culture plates. The plasmid
encoding dominant negative mutant of PKC-δ or Akt was
prepared by using QIAGEN plasmid DNA preparation
kits and was formulated with Metafectene transfection
reagent according to the manufacturer’s instruction (Bion-
tex Lab., Planegg/Martinsried, Germany). The amount of
tansfection plasmid was kept constant (2 μg of dominant
negative mutant of PKCδ or Akt for each well). The cells
were shifted to serum-free DMEM/F-12 for 24 h before
exposure to PPCSE.
Akt Activity Assay
Akt activity Akt was determined by using an Akt activity
assay kit (BioVision, #K45-40). The cell lysates were pre-
pared according to instructions of manufacturer. Akt
immunoprecipitation was conducted by using an Akt
antibody and protein A sepharose beads, washed by
kinase assay buffer, and then incubated with GSK-3a
protein/ATP mixture. The phosphorylation of GSK-3a
protein was analyzed by 12% SDS-PAGE and blotted
using an anti-phospho-GSK-3a antibody. The activated
Akt exerted as a positive control was generated by incu-
bation with 20% FBS for 30 min.
Shih et al. Journal of Neuroinflammation 2011, 8:104
http://www.jneuroinflammation.com/content/8/1/104
Page 3 of 13Statistical analysis
Data were calculated using GraphPad Prism Program
(GraphPad, San Diego, CA). Quantitative data were ana-
lyzed using one-way analysis of variance (ANOVA) fol-
lowed by Tukey’s honestly significant difference tests
between individual groups. Data were expressed as
mean ± SEM. A value of P < 0.05 was considered to be
significant.
Results
PPCSE induces HO-1 expression and enzymatic activity
To determine the effect of PPCSE on HO-1 expression,
cells were incubated with various concentrations of
PPCSE for the indicated time intervals. As shown in
Figures 1A and 1B, PPCSE induced HO-1 expression in
a concentration- and time-dependent manner, with a
maximal response at a concentration of 30 μg/ml for
24 h. PPCSE also induced HO-1 mRNA accumulation
in a time-dependent manner with a maximal response
within 6 h (data not shown). To further determine if
PPCSE-induced HO-1 expression required either tran-
scriptional or translational process, a transcriptional
level inhibitor (actinomycin D, Act.D) and a transla-
tional level inhibitor (cycloheximide, CHX) were used
for these purposes. As shown in Figure 1C, pretreatment
with either Act.D or CHX attenuated PPCSE-induced
Figure 1 PPCSE induces HO-1 protein and activity in bEnd.3 cells. A: Cells were treated with various concentrations of PPCSE for 24 h. B:
Cells were treated with 30 μg/ml PPCSE for the indicated time intervals. C: Cells were pretreated with actinomycin D (Act.D) or cycloheximide
(CHX) for 1 h, and then incubated with PPCSE for 24 h. A, B, C: The expression of HO-1 was determined by Western blot analysis. D: Cells were
treated with various concentrations of PPCSE for 24 h, and then the activity of HO-1 was determined. Data are expressed as the mean ± SEM of
three individual experiments. A, B, D:
#P < 0.05 as compared with the cells exposed to vehicle alone. C:
#P < 0.05 as compared with the cells
exposed to PPCSE alone.
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These findings demonstrated that the induction of
HO-1 by PPCSE depends on de novo protein synthesis.
In addition, we found that PPCSE concentration-depen-
dently increased HO-1 enzyme activity in bEnd.3 cells
(Figure 1D).
Involvement of NADPH oxidase in PPCSE-induced HO-1
expression
PPCSE has been shown to induce the expression of
inflammatory proteins associated with various inflamma-
tory responses [25,26]. NADPH oxidase is an important
enzymatic source for the production of ROS under var-
ious pathological conditions. The ingredients of PPCSE
also induce endogenous ROS generation via a NADPH
oxidase pathway in endothelial cells [27]. To determine
if PPCSE also induced intracellular ROS generation in
bEnd.3 cells, DCF-DA was used as a fluorescence indi-
cator to measure the intracellular ROS levels. As shown
in Figures 2A, PPCSE markedly increased ROS produc-
tion and NADPH oxidase activity within 30 min, which
were attenuated by pretreatment with NAC (a scavenger
of ROS) or the inhibitors of NADPH oxidase (DPI and
APO). In addition, PPCSE-induced HO-1 protein
expression was inhibited by pretreatment with APO
(Figure 2B). These results suggested that PPCSE-induced
HO-1 expression was mediated through NADPH oxi-
dase-dependent ROS generation in bEnd.3 cells.
PPCSE-induced HO-1 expression is mediated by a PC-PLC/
PKCδ/NADPH oxidase cascade
To investigate the role of PKC in PPCSE-induced HO-1
expression, cells were pretreated with the non-specific
inhibitors of PKC (GF109203X and Ro318220), inhibitor
of calcium-dependent PKC (Gö6976) or inhibitor of
PKCδ (rottlerin) prior to the incubation with PPCSE for
24 h. As shown in Figures 3A-D, pretreatment with
GF109203X (GFX), Ro318220 (Ro), or rottlerin (Rott),
but not Gö6976 (Gö), markedly inhibited PPCSE-
induced HO-1 expression, suggesting that Ca
2+-indepen-
dent PKCs such as PKCδ would have predominant role
in PPCSE-induced HO-1 expression. To further ensure
t h er o l eo fP K C δ in the expression of HO-1 induced by
PPCSE, cells were transfected with a dominant negative
mutant of PKCδ.A ss h o w ni nF i g u r e3 E ,t r a n s f e c t i o n
with a dominant negative mutant of PKCδ significantly
attenuated PPCSE-induced HO-1 expression. The activ-
ity of PKC was increased within 3-10 min in response
to PPCSE, determined by an ELISA kit (Figure 3F). Pre-
treatment with rottlerin also decreased NADPH oxidase
activity and ROS generation (Figure 3G).
PKC can be activated by DAG which was cleavage
from PIP2 catalyzed by phospholipase C (PLC) enzymes
[28]. To determine whether the expression of HO-1
induced by PPCSE was mediated via phosphatidylcho-
line PLC (PC-PLC) or phosphatidylinositide PLC (PI-
PLC), cells were pretreated with the inhibitor of PI-PLC
(U73122) or PC-PLC (D609), and then incubated with
PPCSE for 24 h. As shown in Figures 4A and 4B, pre-
treatment with D609, but not with U73122, inhibited
PPCSE-induced HO-1 expression, suggesting that
PPCSE-induced HO-1 expression is mediated through
Ca
2+-independent PC-PLC. This note was further sup-
ported by a PC-PLC activation assay, as shown in Figure
4C, PPCSE increased PC-PLC enzymatic activity within
1-3 min. These results suggested that the expression of
HO-1 induced by PPCSE was mediated via Ca
2+-inde-
pendent PC-PLC in bEnd.3 cells. In addition, PKCδ was
translocated to cell membrane in a time-dependent
manner with a maximal response within 3-10 min
under PPCSE stimulation, which was attenuated by
D609 (Figure 4D). These results indicated that PPCSE-
induced HO-1 expression was mediated through a PC-
PLC/PKCδ-dependent signaling pathway.
Akt plays an important role in PPCSE-induced HO-1
expression
We have recently shown that PDGFR plays a role in
PPCSE-induced HO-1 expression in bEnd.3 cells [11]. In
order to elucidate whether PI3K/Akt, which is a well
known downstream component of PDGFR, involved in
PPCSE-induced HO-1 expression, the inhibitors of PI3K,
wortmannin and LY294002, were used. As shown in
Figures 5A and 5B, PPCSE-induced HO-1 expression was
attenuated by pretreatment with either wortmannin
(Wort) or LY294002 (LY) in a concentration-dependent
manner. To ensure the involvement of PI3K/Akt in
PPCSE-induced HO-1 expression, an Akt dominant nega-
tive mutant was used. As shown in Figure 5C, transfection
of cells with a dominant negative mutant of Akt attenu-
ated PPCSE-induced HO-1 expression in bEnd.3 cells. We
also detected the Akt kinase activity stimulated by PPCSE.
As shown in Figure 5D, the Akt activity, which was indi-
cated by phosphorylated-GSK-3a, was increased in a
time-dependent manner with a maximal response within
30 min. We further determined whether PPCSE-induced
responses were mediated through Akt which was translo-
cated into nucleus. Our results showed that PPCSE stimu-
lated translocation of Akt in a time-dependent manner
(Figure 5E). These data indicated that PPCSE-induced
HO-1 expression was mediated through a PI3K/Akt-
dependent pathway in bEnd.3 cells.
Involvement of NADPH oxidase/ROS in sequential
activation of PDGFR/PI3K/Akt induced by PPCSE
PPCSE has been shown to stimulate phosphorylation of
PDGFR and Akt leading to expression of several target
proteins such as HO-1. To investigate if there was a
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Page 5 of 13Figure 2 PPCSE-induced HO-1 expression is mediated via NADPH oxidase-dependent ROS generation in bEnd.3 cells. A: bEnd.3 cells
were labeled with DCF-DA (10 μM), and then incubated with 30 μg/ml PPCSE for 30 min with/without pretreatment of NAC (3 mM), DPI (1 μM)
or APO (1 μM) for 1 h. The fluorescence intensity (relative DCF fluorescence) was measured at 495 nm excitation and 529 nm emission using a
FACScan flow cytometer. The NADPH oxidase activity was measured as described in the Methods. B: Cells were pretreated with APO for 1 h,
and then incubated with PPCSE for 24 h. The expression of HO-1 was determined by Western blot. Data are summarized and expressed as the
mean ± SEM of three individual experiments. *P < 0.05 as compared with the cells exposed to vehicle alone.
#P < 0.05 as compared with the
cells exposed to PPCSE alone.
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Page 6 of 13Figure 3 PPCSE-induced HO-1 expression is mediated by PKCδ in bEnd.3 cells. A-D: Cells were pretreated with non-selective inhibitors of
PKC, GF109203X (GFX) and Ro318220 (Ro), and Gö6976 (Gö) or selective inhibitor of PKCδ, rottlerin (Rott) for 1 h, and then incubated with
PPCSE for 24 h. The expression of HO-1 was determined by Western blot. E: Cells were transfected with a dominant negative mutant of PKCδ
(ΔPKCδ), and then incubated with PPCSE for 24 h. The expression of HO-1 was determined by Western blot. F: Cells were treated with 30 μg/ml
PPCSE for the indicated time intervals, and then the activity of PKC was determined as described in the Methods. G: Cells were pretreated with
rottlerin (Rott) for 1 h, and then incubated with PPCSE for 1 h. The ROS generation and NADPH oxidase activity were measured. Data are
expressed as the mean ± SEM of three independent experiments performed in triplicate. A-F:
#P < 0.05 as compared with the cells exposed to
PPCSE alone. G:
#P < 0.05 as compared within groups.
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wortmannin (inhibitor for PI3K) and AG1296 (inhibitor
for PDGFR) were used. As shown in Figure 6A, PPCSE
stimulated Akt phosphorylation in a time-dependent
manner, which was attenuated by pretreatment with
inhibitor of either PI3K (wortmannin) or PDGFR
(AG1296) during the period of observation. However
PPCSE-stimulated phosphorylation of PDGFR was not
inhibited by wortmannin (Figure 6B). The data indicated
that PI3K/Akt was a downstream component of PDGFR
for PPCSE-induced HO-1 expression in bEnd.3 cells.
We further clarified the involvement of PC-PLC/PKCδ/
NADPH oxidase/ROS in PPCSE-stimulated activation of
PDGFR/PI3K/Akt pathway. As shown in Figure 6C, pre-
treatment with either D609 (an inhibitor of PC-PLC),
rottlerin (an inhibitor of PKCδ), APO (an inhibitor of
NADPH oxidase) or NAC (a ROS scavenger) signifi-
cantly reduced PPCSE-stimulated phosphorylation of
PDGFR and Akt. These results suggested that PPCSE-
stimulated PDGFR/PI3K/Akt cascade was mediated via
PC-PLC/PKCδ/NADPH oxidase/ROS signaling pathway.
Discussion
HO-1 upregulation has been observed in various types of
cells exposed to diverse agents. Although PPCSE-induced
oxidative stress and HO-1 expression has been extensively
studied, the molecular mechanisms by which PPCSE
induces oxidative stress and HO-1 expression are not fully
understood in brain endothelial cells. In this study, we
used murine brain endothelial cells (bEnd.3) as a model to
demonstrate that the levels of HO-1 protein and their
activity were increased upon exposure to PPCSE. In the
present study, western blot analysis coupling with pharma-
cological inhibitors and transfection with dominant nega-
tive mutants revealed that PPCSE-induced HO-1
expression was regulated by activation of PDGFR-depen-
dent PI3K/Akt pathway, which was mediated through
PKCδ/NADPH oxidase/ROS. These results suggest that
PKCδ/NADPH oxidase/ROS-dependent PDGFR/PI3K/
Akt activation could play an important role in PPCSE-
induced HO-1 expression in bEnd.3 cells.
Cerebral endothelial dysfunction induced by oxidative
stress [29,30] or excitoneurotoxicity [31] has been
Figure 4 PPCSE-induced HO-1 expression is mediated via a PC-PLC/PKCδ signaling in bEnd.3 cells.A ,B :C e l l sw e r ep r e t r e a t e dw i t ht h e
inhibitor of PI-PLC (U73122) or PC-PLC (D609) for 1 h, and then incubated with PPCSE for 24 h. The expression of HO-1 was determined by
Western blot. C: Cells were treated with 30 μg/ml PPCSE for the indicated time intervals, and then the activity of Ca
2+-independent PC-PLC was
determined as described in the Methods. The basal level of Ca
2+-independent PC-PLC was 27.4 ± 3.44 nmol/min/mg protein. D: Cells were
pretreated with D609 for 1 h, and then incubated with PPCSE for the indicated time intervals. The cytosolic and membrane fractions were prepared
and subjected to 12% SDS-PAGE to determine the translocation of PKCδ using an anti-PKCδ antibody. Data are summarized and expressed as the
mean ± SEM of three individual experiments. *P < 0.05 as compared with the cells exposed to PPCSE alone.
#P < 0.05 as compared with basal level.
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beneficial for cerebral ischemic injury [32,33]. However,
HO-1 has been recently demonstrated to exacerbate
early brain injury produced by intracerebral haemorrha-
gic stroke [6]. Hence, HO-1 may play different roles in
ischemic or haemorrhagic stroke injury. PPCSE-induced
HO-1 expression in cerebrovascular cells is therefore an
important issue for brain injury in the field of CS
toxicity.
It should be noted that the PPCSE used in this study was
collected on a Cambridge filter, which traps particulate
matter but not the gas phase. Within the particulate of
PPCSE, lipophilic components are also present other than
ROS. Lipophilic components are able to pass the lipid
bilayer [1]. Therefore, it is possible that particulate matter
of PPCSE dissolved in blood stream can reach brain ves-
sels. Hence, the highly reactive lipophilic components
such as polycyclic aromatic hydrocarbons, aldehydes, phe-
nols, heavy metals, and amines could easily enter the brain
through the blood-brain barrier.
Several isoforms of PKC have been found to mediate
several cellular responses [34]. On the other hand, PKC
has been also shown to regulate HO-1 expression [35].
Recently, PPCSE has been shown to activate PKC
Figure 5 Akt mediated HO-1 induction by PPCSE. A, B: Cells were pretreated with wortmannin (Wort) or LY294002 (LY) for 1 h, and then
incubated with PPCSE for 24 h. The expression of HO-1 was determined by Western blot. C: Cells were transfected with a dominant negative
mutant of Akt (ΔAkt), and then incubated with PPCSE for 24 h. The expression of HO-1 was determined by Western blot. D: Akt kinase activity
was determined as described in the Methods. Cells were treated with 30 μg/ml PPCSE for the indicated time intervals. Phosphorylation of GSK-
3a was used to determine the activity of Akt stimulated by PPCSE and analyzed by western blot. E: Time dependence of PPCSE-stimulated Akt
translocation into nucleus. Cells were treated with 30 μg/ml PPCSE for the indicated time intervals. The cytosolic and nuclear fractions were
analyzed by Western blot using an anti-Akt, anti-GAPDH (as a cytosol control), or anti-a-actin (as a nuclear control) antibody. A-C: Data are
expressed as the mean ± SEM of three individual experiments.
#P < 0.05 as compared with the cells exposed to PPCSE alone. D, E: Similar results
were obtained from three independent experiments.
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Page 9 of 13Figure 6 PPCSE-induced HO-1 expression is mediated via a NADPH oxidase/ROS/PDGFR/PI3K/Akt signaling in bEnd.3 cells. A, B:C e l l s
were pretreated without or with wortmannin (Wort, 1 μM) or AG1296 (3 μM) for 1 h, and then stimulated with 30 μg/ml PPCSE for the
indicated time intervals. The cell lysates were analyzed by Western blot using an anti-phospho-PDGFR, anti-phospho-Akt, or anti-GAPDH
antibody. C: Cells were pretreated without or with D609 (an inhibitor of PC-PLC), rotterin (an inhibitor of PKCδ), APO (an inhibitor of NADPH
oxidase), or NAC (a ROS scavenger) for 1 h, and then stimulated with 30 μg/ml PPCSE for the indicated time intervals. The phosphorylations of
Akt and PDGFR were determined by Western blot. Similar results were obtained from three independent experiments.
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Page 10 of 13isoforms in rat bronchial smooth muscle cells [36]. In the
present study, Ca
2+-independent PKC, PKCδ,m e d i a t e d
H O - 1i n d u c t i o ni nr e s p o n s et oP P C S E ,w h i c hw a sc o n -
firmed by transfection of cells with a dominant negative
mutant of PKCδ. PLC enzymes catalyze the cleavage of
phospholipids and result in the release of diacylglycerol
(DAG) in response to receptor activation and the DAG
can trigger the activation of PKC [28]. In the present
study, we found that D609 inhibited HO-1 expression
induced by PPCSE, suggesting that PPCSE-induced HO-
1 expression was mediated through PC-PLC. On the
other hand, according to the kinetic studies, a maximal
activation of PC-PLC was obtained within 1-3 min
(Figure 4C), while a maximal activation of PKCδ was
obtained within 3-10 min (Figure 3F). In addition, PKCδ
translocation was attenuated by D609 (Figure 4D). These
data suggested that PC-PLC may be an upstream compo-
nent of PKC in these responses. Taken together, these
results suggested that PPCSE-induced HO-1 expression
was mediated through PC-PLC/PKCδ pathway in bEnd.3
cells.
The NADPH oxidase systems contribute as a major
source of O2
.-, which are present in endothelial cells,
smooth muscle cells, and infiltrated monocytes/macro-
phages [37,38]. Oxidative stress occurs when the flux of
ROS or free radical generation exceeds available antioxi-
dant defenses. The NADPH oxidase family members are
proteins that transfer electrons across biological mem-
branes. In general, the electron acceptor is oxygen and the
product of the electron transfer reaction is a superoxide.
Therefore, the biological function of NADPH oxidase
might be attributable to the production of ROS [39]. The
aim of the present study was to examine whether the pro-
duction of ROS in response to PPCSE that depends on
NADPH oxidase activity led to the expression of HO-1.
Previous study indicated that one of the early events
occurring in smoke-exposed cells is the generation of ROS
[40]. In the present study, ROS generation induced by
PPCSE was attenuated by pretreatment with the inhibitors
of NADPH oxidase, suggesting that PPCSE induced ROS
production in an NADPH oxidase-dependent manner.
Moreover, it has been shown that PKC-dependent
p47
phox phosphorylation and translocation are major
mechanisms involved in NADPH oxidase activation [37]
and ROS production [41,42]. Consistent with these stu-
dies, our results further showed that PPCSE-enhanced
NADPH oxidase activity was attenuated by pretreatment
with rottlerin, a PKCδ inhibitor. The involvement of
PKCδ in PPCSE-mediated response was further con-
firmed by trasfection with dominant negative mutant of
PKCδ which attenuated HO-1 expression. These results
suggest that PPCSE-stimulated NADPH oxidase/ROS
generation and HO-1 expression was mediated through
activation of PKCδ.
It has been reported that several GPCRs initiate the
PI3K/Akt pathway through transactivation of the EGFR
or PDGFR in various cell types [43,44]. The downstream
Akt phosphorylation was also mediated through transac-
tivation of these growth factor receptors [45]. In the pre-
sent study, PPCSE induced the phospharylation of Akt,
with a maximal response within 30 min (Figure 6A). In
addition, PPCSE stimulated the translocation of Akt from
the cytosol to the nucleus, with a maximal response
within 30 min (Figure 5E). On the other hand, a maximal
phosphorylation of PDGFR was obtained within 3-10
min (Figure 6B). The phosphorylation of Akt induced by
PPCSE was also inhibited by pretreatment with AG1296
(Figure 6A). These data suggested that PDGFR is an
upstream component of Akt in PPCSE-mediated
responses. CS can activate several signaling pathways
including EGFR/PDGFR [46]. Our recent report with
AG1296 and PDGFR shRNA demonstrated that PDGFR
plays an important role in PPCSE-induced HO-1 expres-
sion in bEnd.3 cells [11]. However, little was known
about the mechanisms of PPCSE that initiates the expres-
sion of HO-1 mediated through NADPH/ROS-depen-
dent transactivation of PDGFR/PI3K/Akt in bEnd.3 cells.
Our present results demonstrated that pretreatment with
NAC or APO significantly reduced PPCSE-stimulated
phosphorylation of PDGFR or Akt, suggesting the invol-
vement of NADPH/ROS in PPCSE-induced PDGFR/
PI3K/Akt activation. In addition, PKCδ was involved in
PPCSE-induced NADPH oxidase activation, suggesting
that PPCSE-induced HO-1 expression was mediated
through a PKCδ/NADPH oxidase/ROS/PDGFR signaling.
In addition to these signaling components involved in
PPCSE-induced responses, MAPKs have been shown to
regulate HO-1 expression in various cell types [47,48].
Thus, the relationship between PKCδ/NADPH oxidase/
ROS and MAPKs in response to PPCSE will be further
investigating in bEnd.3 cells.
It has been shown that a known toxin in tobacco smoke,
acrolein, induced HO-1 expression through two indepen-
dent pathways, PKCδ or PI3K, in human bronchial epithe-
lial cells [18]. In that report, PKCδ appears to regulate
HO-1 induction via modulating Nrf2 nuclear transloca-
tion, while PI3K may work through targeting on down-
stream signaling molecules other than Nrf2. However, in
the present study, our results demonstrated that PKCδ
activated PDGFR/PI3K/Akt signaling mediated through
NADPH oxidase/ROS in bEnd.3 cells. The discrepancy
may be due to cellular specificity or difference between
pure compound and mixture.
Conclusions
In summary, as depicted in Figure 7, our results showed
that in bEnd.3 cells, PPCSE-induced HO-1 expression
was, at least in part, mediated through PC-PLC/PKCδ/
Shih et al. Journal of Neuroinflammation 2011, 8:104
http://www.jneuroinflammation.com/content/8/1/104
Page 11 of 13NADPH oxidase/ROS-dependent PDGFR/PI3K/Akt sig-
naling pathway.
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